Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo

Journal of Human Hypertension volume 15, pages 863–867 (2001)Cite this article

Abstract

The objective of this study was to compare the quality of life and incidence of dry cough with the angiotensin II antagonist eprosartan, the ACE-inhibitor enalapril, and placebo, in hypertensive patients with a history of ACE-inhibitor cough. The study was a multicentre, randomised, double-blind, parallel group controlled trial. A total of 136 patients judged to have ACE-inhibitor cough during single-blind enalapril treatment which was lost during a subsequent placebo washout phase, were randomised to receive either eprosartan 300 mg twice daily, or enalapril 20 mg once daily, or placebo for 6 weeks. Self-completion questionnaires assessing quality of life and cough were examined at baseline and end of study. At study end point 23% of patients in the enalapril group and 5% in the eprosartan and placebo groups reported cough (which included definite, probable and possible coughs) (P = 0.02). After adjusting for multiple comparisons, the eprosartan group was not significantly different from either placebo or enalapril. There were no significant differences in the Psychological General Wellbeing Index (PGWB). In conclusion the incidence of self-reported cough on eprosartan was similar to that on placebo, and lower than on enalapril but this difference was not significant when adjustments were made for multiple comparisons. There were no differences in quality of life.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Fletcher AE, Palmer AJ, Bulpitt CJ Cough with angiotensin converting enzyme inhibitors: how much of a problem? J Hypertens 1994 12 (Suppl 2) S43–S47

    Google Scholar 

  2. Yeo WW, Ramsay LE Persistent dry cough with enalapril: incidence depends on method used J Hum Hypertens 1990 4 517–520

    CAS  PubMed  Google Scholar 

  3. Lacourcière Yet al,and the Losartan Cough Study GroupEffects of modulators of the renin-angiotensin-aldosterone system on cough J Hypertens 1994 12 1387–1393

    PubMed  Google Scholar 

  4. Ramsay LE, Yeo WW, on behalf of the Losartan Cough Study Group ACE inhibitors, angiotensin II antagonists and cough J Hum Hypertens 1995 9 (Suppl 5) S51–S54

    Google Scholar 

  5. Ramsay LE, Yeo WW, on behalf of the Losartan Cough Study Group Double-blind comparison of losartan, lisinopril and hydrochlorothiazide in hypertensivepatients with a previous angiotensin converting enzyme inhibitor-associated cough J Hypertens 1995 13 (Suppl 1) S73–S76

    Article  Google Scholar 

  6. Chan P et alDouble-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensivepatients with previous angiotensin-converting enzyme inhibitor-induced cough J Clin Pharmacol 1997 37 253–257

    Article  CAS  PubMed  Google Scholar 

  7. Dupuy HJ The Psychological General Wellbeing Index. In: Wenger NK, Mattson ME, Furberg CD,Eliason J (eds) Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies Le Jacq: New York 1984 pp 170–183

    Google Scholar 

  8. Wiklund I, Halling K, Lngström G The Psychological General Wellbeing Index (PGWB), a reliable tool for use in cross-cultural multicentre clinical trials (abstract) Qual Life Res 1995 4 503

    Google Scholar 

  9. Badia X, Gutiérrez F, Wiklund I, Alonso J Validity and reliability of the Spanish version of the Psychological General Wellbeing Index Qual Life Res 1996 5 101–108.

    Article  CAS  PubMed  Google Scholar 

  10. Bulpitt CJ, Fletcher AE Measurements of quality of life in hypertension: a practical approach Br J Clin Pharmacol 1990 30 353–364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Crown S, Crisp AH A short diagnostic self-rating scale for psychoneuroticpatients Br J Psychiatr 1966 112 917–923

    Article  CAS  Google Scholar 

  12. Developed in the Rand Corporation, Santa Monica, California

  13. Kazis LE, Anderson JJ, Meenan RS Effect sizes for interpreting changes in health statistics Med Care 1989 27 178–189

    Article  Google Scholar 

  14. Hochberg Y A sharper Bonferroni procedure for multiple tests Biometrika 1988 75 800–802

    Article  Google Scholar 

  15. Paster RZ et alUse of Iosartan in the treatment of hypertensivepatients with a history of cough induced by antiotensin-converting enzyme inhibitors Clin Ther 1998 20 978–989

    Article  CAS  PubMed  Google Scholar 

  16. Reisin L, Schneeweiss A Complete spontaneous remission of cough induced by ACE-inhibitors during chronic therapy in hypertensivepatients J Hum Hypertens 1992 6 333–335

    CAS  PubMed  Google Scholar 

  17. Reisin L, Schneeweiss A Spontaneous disappearance of cough induced by angiotensin-converting enzyme inhibitors (captopril or enalapril) Am J Cardiol 1992 70 398–399

    Article  CAS  PubMed  Google Scholar 

  18. Israili ZH, Hall WD Cough and angioneurotic oedema associated with angiotensin converting enzyme inhibitor therapy Ann Intern Med 1992 117 234–242

    Article  CAS  PubMed  Google Scholar 

  19. Yeo WW, Foster G, Ramsay L Prevalence of persistent cough during long term enalapril treatment: controlled study versus nifedipine Q J Med 1991 293 763–770

    Google Scholar 

  20. Os I et alFemale sex as an important determination of lisinopril-induced cough (letter) Lancet 1992 339 372

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The project was funded by Smithkline Beecham Pharmaceutical Inc (since merged into GlaxoSmithkline).

Author information

Authors and Affiliations

  1. Institute for Cancer Research, London School of Hygiene and Tropical Medicine (LSHTM), London, UK

    EC Rake

  2. Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK

    E Breeze & AE Fletcher

Authors
  1. EC Rake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Breeze
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. AE Fletcher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Breeze.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rake, E., Breeze, E. & Fletcher, A. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo. J Hum Hypertens 15, 863–867 (2001). https://doi.org/10.1038/sj.jhh.1001283

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001283

Keywords

This article is cited by

Search

Advanced search

Quick links